LIVING CELL TECHNOLOGIES
LCT is a cell-based biotechnology developing insulin producing porcine pancreatic islets for the treatment of type 1 diabetes . LCT's lead product, DIABECELL is in Phase II clinical trial. LCT's encapsulation technology immunoisolates cells and allows cell implants without the use of immunosuppressive drugs.
LIVING CELL TECHNOLOGIES
Social Links:
Industry:
Biotechnology Diabetes Health Care Health Diagnostics
Founded:
1987-01-01
Address:
Manukau City, Auckland, New Zealand
Country:
New Zealand
Website Url:
http://www.lctglobal.com
Total Employee:
11+
Status:
Active
Contact:
64 9 276 2690
Email Addresses:
[email protected]
Total Funding:
6.28 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Google Tag Manager Google Universal Analytics Global Site Tag
Current Employees Featured
Founder
Stock Details
Company's stock symbol is ASX:LCT
Official Site Inspections
http://www.lctglobal.com Semrush global rank: 8.71 M Semrush visits lastest month: 262
Unable to get host informations!!!
Loading ... 